ArticleMolecular biomedicine2026

An inducible co-stimulator ligand (ICOSL)-based peptide therapy for proteinuric kidney diseases targeting αvβ3 integrin.

Alexis P Jimenez-Uribe et al.PubMed ↗Publisher ↗

No numbers read from the abstract.